Three Month Clinical Evaluation of the Contamac 74% Silicone Hydrogel Contact Lens

Vision Correction Clinical Trial

Official title:
Three Month Clinical Evaluation of the Contamac 74% Silicone Hydrogel Contact Lens

Status Completed

Clinical Trial Summary

The purpose of this study is to compare the clinical performance of the contamac silicone hydrogel contact lens with a predicate device (Cooper Vision Biofinity).

Clinical Trial Description

The purpose of this study is to evaluate the clinical performance of the Contamac lens in comparison with a currently marketed silicone hydrogel: Biofinity® (CooperVision). This is a 3-month, open-label, bilateral, parallel group, randomised, daily wear study. Approx. two-thirds of the subjects will wear the Contamac Silicone Hydrogel lens in both eyes while the other third will wear control lenses. ;

Study Design

Related Conditions & MeSH terms

Vision Correction

Clinical Trial Details

NCT number	NCT01197859
Study type	Interventional
Source	Contamac Ltd
Contact
Status	Completed
Phase	N/A
Start date	August 2008
Completion date	February 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02036320` - A Non-dispensing Fit Evaluation of Investigational Limbal Ring Soft Contact Lenses With Polyvinylpyrrolidone (PVP) in Asian Eyes	N/A
Completed	`NCT00630305` - Endothelial Bleb Response With Toric Lenses	N/A
Completed	`NCT02394925` - Acceptance & Tolerance Study of Multifocal Contact Lenses by Functional Emmetropes	N/A
Completed	`NCT00638846` - Performance of Two Silicone Hydrogel Toric Contact Lenses	N/A
Completed	`NCT01061294` - Evaluation of Outcomes Using the AMO Advanced Customvue™ iLasik Procedure	Phase 4